샘플 요청 목록

 카트 문의
시장보고서
상품코드
1594912

세계의 환자 혈액 관리 시장

Patient Blood Management
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 93 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 환자 혈액 관리 시장은 2030년까지 236억 달러에 달할 전망

2023년에 152억 달러로 추정되는 세계의 환자 혈액 관리 시장은 2023-2030년 CAGR 6.4%로 성장하며, 2030년에는 236억 달러에 달할 것으로 예측됩니다. 본 리포트에서 분석한 부문의 하나인 기기는 CAGR 6.5%를 기록하며, 분석 기간 종료시에는 101억 달러에 달할 것으로 예측됩니다. 시약·키트 분야의 성장률은 분석 기간의 CAGR로 7.1%로 추정됩니다.

미국 시장은 추정 40억 달러, 중국은 CAGR 9.8%로 성장 예측

미국의 환자 혈액 관리 시장은 2023년에 40억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2023-2030년의 분석 기간에 CAGR 9.8%로 추이하며, 2030년에는 예측 시장 규모가 56억 달러에 달할 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 3.3%와 5.8%로 예측됩니다. 유럽에서는 독일이 CAGR 3.7%로 성장할 것으로 예측됩니다.

세계의 환자 혈액 관리 시장 - 주요 동향과 촉진요인 정리

현대 헬스케어에서 환자 혈액 관리가 필수적인 이유는?

환자 혈액 관리(PBM)는 수혈이 필요한 환자의 치료를 최적화하기 위한 체계적인 접근 방식을 제공함으로써 현대 의료에서 매우 중요한 요소로 자리 잡았으며, 빈혈을 관리하고 수술 중 출혈을 줄이며 환자의 적혈구 수치를 최적화하여 수혈의 필요성을 최소화하고 감염, 면역 반응, 수혈 관련 합병증 등 수혈과 관련된 위험을 줄임으로써 환자의 안전과 임상 결과를 개선하는 데 초점을 맞추었습니다. PBM의 중요성은 감염, 면역 반응, 수혈 관련 합병증 등 수혈과 관련된 위험을 줄여 환자의 안전을 향상시키는 능력에 있습니다. 이러한 증거 기반 접근법은 혈액제제에 대한 의존도를 낮추고 조기 회복으로 이어지기 때문에 수술, 외상, 만성 빈혈 환자에게 특히 중요합니다.

PBM은 불필요한 수혈을 최소화함으로써 가용량이 제한적인 혈액 공급을 절약하는 데에도 중요한 역할을 합니다. 이러한 접근 방식은 특히 혈액이 부족하거나 혈액제제에 대한 접근성이 제한된 지역의 의료 시스템에 필수적입니다. 인구 고령화와 수술 증가로 인해 혈액에 대한 수요가 증가하는 가운데, PBM은 혈액을 가장 필요로 하는 환자에게 혈액이 공급될 수 있도록 하면서 효율적인 혈액 사용을 장려합니다. 이러한 관행은 자원을 절약할 뿐만 아니라 수혈과 관련된 의료 비용을 낮춰 PBM을 지속가능한 의료 관리에 필수적인 요소로 만들고 있습니다.

또한 PBM은 각 환자의 혈액 수요를 관리하기 위해 예방적이고 개별화된 접근 방식을 취함으로써 전반적인 결과를 개선할 수 있도록 돕습니다. PBM은 철분 보충, 적혈구 조혈 촉진제, 고급 수술 기법 등의 개입을 통해 수술이나 치료 전에 환자를 충분히 준비시킵니다. 이러한 종합적인 접근 방식은 합병증 발생 가능성을 줄이고 입원 기간을 단축하며 회복 시간을 연장할 수 있습니다. 의료에서 환자 중심의 치료가 점점 더 중요시되는 가운데 PBM은 현대 의료 제공의 원칙에 따라 맞춤형 예방 전략을 제공하여 환자 만족도와 건강 결과를 모두 향상시킬 수 있습니다.

기술의 발전은 어떻게 환자의 혈액 관리를 강화하는가?

기술의 발전은 혈액 사용을 최적화하고 혈액 손실을 최소화하며 환자 예후를 개선하는 새로운 툴와 방법을 도입함으로써 환자 혈액 관리를 크게 개선하고 있습니다. POC(Point-of-Care) 검사 및 자동 혈액 분석기와 같은 기술은 신속한 헤모글로빈 평가 및 철분 결핍 평가를 가능하게 하여 의료진이 빈혈을 조기에 진단하고 치료할 수 있도록 돕습니다. 정확한 실시간 진단을 통해 임상의는 헤모글로빈 수치를 최적화하기 위한 개별화 전략을 사전에 실행하여 수혈이 필요할 가능성을 줄일 수 있습니다. 이러한 기술은 PBM의 핵심 요소인 예방적 빈혈 관리를 지원하여 환자가 치료를 받기 전에 최상의 상태를 유지할 수 있도록 보장합니다.

PBM의 또 다른 큰 발전은 수술 중 출혈을 최소화하고 수혈의 필요성을 감소시키는 세포 회수 및 혈액 보존 수술 기법의 사용입니다. 수술 중 세포구출 장비는 수술 중 환자의 혈액을 회수 및 처리하여 환자에게 다시 주입할 수 있도록 하여 기증자 혈액에 대한 의존도를 낮출 수 있습니다. 또한 최소 침습 수술과 복강경 수술은 절개창이 작아 출혈이 적기 때문에 점점 더 보편화되고 있습니다. 이러한 수술은 정형외과수술이나 심장 수술과 같이 출혈이 많은 수술에서 특히 유용합니다. PBM은 세포 회수 및 최소 침습 기술을 도입하여 외부 혈액의 필요성을 줄이고, 수술 결과를 개선하며, 자원 효율성을 지원합니다.

적혈구 조혈자극제(ESA)와 철분 보충제와 같은 의약품 혁신도 적혈구 생성을 촉진하고 수혈 없이 빈혈을 치료하는 데 중요한 역할을 하고 있으며, ESA는 골수를 자극하여 더 많은 적혈구를 생성하도록 도와주기 때문에 만성 빈혈 환자나 화학요법을 받는 환자에게 특히 유용합니다. 만성 빈혈 환자나 화학요법을 받는 환자에게 특히 유용합니다. 철분 보충제는 경구 또는 정맥 주사를 통해 헤모글로빈을 최적화하고 출혈을 동반할 수 있는 시술에 대비할 수 있도록 지원하며, PBM은 수혈의 필요성을 최소화하면서 환자의 건강을 증진시킨다는 목표에 따라 이러한 약물 중재를 통해 빈혈 관리를 위한 비수혈 옵션을 제공합니다. 제공합니다. 이러한 치료법은 임상의가 각 환자의 필요에 따라 PBM 전략을 조정할 수 있도록 하여 혈액 관리에 대한 보다 효과적이고 덜 침습적인 접근 방식을 제공합니다.

환자의 혈액 관리는 환자와 의료 서비스 프로바이더에게 어떤 이점이 있는가?

환자 혈액 관리는 환자와 의료 서비스 프로바이더 모두에게 큰 이점을 제공하여 환자 결과를 개선하고 의료 비용을 절감하며 제한된 혈액 자원의 사용을 최적화합니다. 환자의 경우, PBM은 감염, 수혈 반응, 면역학적 합병증과 같은 수혈과 관련된 위험을 최소화하여 안전성을 높입니다. PBM은 빈혈 관리, 외과적 보존 기술, 환자 자신의 혈액 사용 등 수혈 이외의 개입을 통해 부작용의 가능성을 줄이고 보다 안전한 의료 서비스를 촉진합니다. 대수술을 받는 환자의 경우, PBM은 환자의 건강을 우선시하고 수혈의 필요성을 줄여 회복 시간을 단축하고 입원 기간을 단축할 수 있도록 세심하게 관리되는 혈액 전략을 보장합니다.

PBM은 의료기관의 경우, 공급이 제한적인 헌혈자 혈액에 대한 의존도를 낮춰 효율적이고 지속가능한 자원 관리를 돕습니다. 헌혈률이 수요 증가를 따라잡지 못하는 상황에서 PBM은 외상이나 중증 출혈 환자 등 중요한 필요가 있는 환자들을 위해 혈액 자원을 확보하는 데 도움이 됩니다. 최적화된 치료와 수혈 이외의 개입을 통해 혈액 사용량을 줄임으로써 의료 서비스 프로바이더는 자원을보다 효과적으로 관리하여 혈액 부족 위험을 낮추고 실제로 필요할 때 혈액 제제를 사용할 수 있도록합니다, 수혈과 관련된 비용을 절감합니다. 이러한 비용 효율성은 혈액 자원을 효과적으로 관리함으로써 상당한 재정적 절감으로 이어지는 대규모 병원 및 의료 시스템에서 특히 가치가 있습니다.

PBM의 또 다른 장점은 환자 결과와 치료의 질을 향상시켜 환자 중심의 개별화된 의료 접근을 촉진하는 것입니다. PBM은 빈혈 조기 발견, 혈액을 절약하는 수술, 수혈을 하지 않는 선택 등을 통해 의료 프로바이더가 각 환자의 필요에 맞는 맞춤 치료 계획을 세울 수 있게 해줍니다. 이러한 맞춤형 접근 방식은 합병증 발생 가능성을 줄이고, 빠른 회복을 지원하며, 환자 만족도와 전반적인 치료의 질을 향상시킬 수 있습니다. 환자의 혈액 건강 상태를 적극적으로 관리함으로써 PBM은 입원 및 재입원을 최소화하고 보다 합리적인 의료 경험을 제공합니다. 이러한 장점은 의료 서비스 제공의 임상적 측면과 운영적 측면을 모두 개선하여 양질의, 비용 효율적이며 환자 중심의 치료라는 목표를 지원합니다.

환자 혈액 관리 시장의 성장을 가속하는 요인은 무엇인가?

환자 혈액 관리 시장 성장의 원동력은 수혈 관련 위험에 대한 인식 증가, 수술 및 만성질환 사례 증가, 진단 및 치료 기술 발전, PBM 도입을 촉진하는 규제 당국의 지원 정책 등이 있습니다. 수혈과 관련된 위험과 합병증에 대한 인식이 높아짐에 따라 의료 서비스 프로바이더들은 기존의 수혈 방법을 대체할 수 있는 보다 안전하고 효과적인 방법을 찾고 있습니다. 감염, 면역학적 반응, 잠재적 합병증에 대한 우려는 수혈을 최소화하고 보다 안전한 치료 옵션을 제공하는 PBM 프로그램의 필요성을 강조하고 있습니다. 이러한 임상적 관점의 변화로 인해 더 많은 병원과 의료 기관이 PBM 프로토콜을 채택하고 있으며, 종합적인 혈액 관리를 지원하는 기술과 방법에 대한 수요가 증가하고 있습니다.

수술 건수 증가와 암, 신장질환, 심혈관 질환과 같은 만성질환의 유병률 증가도 PBM 솔루션에 대한 수요를 촉진하고 있습니다. 이러한 질환은 수술이나 잦은 입원을 필요로 하는 경우가 많기 때문에 의료진은 수혈에 대한 의존도를 줄이면서 환자 치료를 지원하는 효과적인 혈액 관리 전략이 필요하며, PBM 프로토콜은 수술 전과 수술 중 환자의 혈액 상태를 최적화하여 수혈의 필요성을 줄여줍니다. 수혈의 필요성을 줄일 수 있으므로 출혈이 많은 수술에 특히 유용합니다. 수술 및 입원 건수가 계속 증가함에 따라 혈액을 효율적으로 관리하고 환자 예후를 개선하기 위한 효과적인 PBM 솔루션에 대한 수요도 계속 증가하고 있습니다.

진단 및 치료 기술의 발전은 보다 정확하고 효과적인 맞춤형 혈액 관리 전략을 가능하게 함으로써 PBM 시장의 성장에 크게 기여하고 있습니다. 현장 검사 및 고급 빈혈 선별검사와 같은 새로운 진단 툴은 환자의 혈액 수치를 조기에 개입하고 정확하게 관리할 수 있게 해줍니다. 세포 구제 장비와 최소침습적 수술법을 포함한 외과적 혁신은 수술 중 혈액 손실을 줄이고 공여 혈액의 필요성을 최소화합니다. 적혈구 조혈 촉진제 및 정맥내 철분 보충제 등 의약품의 발전은 빈혈 환자에게 수혈 이외의 치료 옵션을 제공합니다. 이러한 기술 혁신은 PBM 프로그램을 보다 쉽고 효과적으로 이용할 수 있게 해주고, 전 세계 병원과 의료 시설에서 PBM 프로그램의 채택을 촉진하고 있습니다.

의료 기관과 정부가 환자 안전을 개선하고 혈액 자원을 최적화하는 데 있으며, PBM의 가치를 인식함에 따라 PBM 시장의 성장을 지원하는 규제 정책과 가이드라인도 PBM 시장의 성장을 가속하고 있습니다. 세계보건기구(WHO)와 같은 규제기관과 여러 국가의 보건부는 의료 서비스 프로바이더가 표준 치료 프로토콜의 일부로 PBM을 채택하도록 장려하고 있습니다. 현재 많은 의료 시스템은 품질 표준을 준수하고 의료 비용을 절감하며 혈액 자원을 절약하기 위해 병원에 PBM 전략을 시행하도록 요구하고 있습니다. 또한 환자 옹호 단체와 의료 기관은 의료 종사자와 일반 대중에게 PBM의 이점을 알리기 위해 교육 활동을 강화하고 있습니다. 이러한 규제와 옹호 노력은 PBM의 채택을 확대하고 의료 서비스 프로바이더가 베스트 프랙티스와 컴플라이언스 표준을 준수함에 따라 시장의 큰 성장을 가속하고 있습니다.

수혈 위험에 대한 인식, 수술 및 만성질환 증가, 기술 발전, 지원적인 규제 프레임워크 등 다양한 요인이 결합되어 환자 혈액 관리 시장은 강력한 성장세를 보이고 있습니다. 의료 시스템이 보다 안전하고 비용 효율적이며 자원 효율적인 의료 서비스를 제공하기 위해 노력하고 있는 가운데, PBM은 환자 중심의 현대적 의료 서비스 제공의 초석이 되고 있습니다.

부문

제품(장비, 시약 & 키트, 소프트웨어, 액세서리);성분(전혈 & 적혈구, 혈장);최종 사용(혈액은행, 병원)

조사 대상 기업의 예(총 42사)

  • Abbott Laboratories
  • Asahi Kasei Medical Co. Ltd.
  • B. Braun Melsungen AG
  • Biomerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche LTD.
  • Fresenius Se & Co. KGaA
  • Grifols, S.A.
  • Haemonetics Corporation
  • Immucor, Inc.
  • Kaneka Corporation
  • Livanova PLC
  • Macopharma
  • Terumo Corporation

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장의 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 24.11.26

Global Patient Blood Management Market to Reach US$23.6 Billion by 2030

The global market for Patient Blood Management estimated at US$15.2 Billion in the year 2023, is expected to reach US$23.6 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Instruments, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$10.1 Billion by the end of the analysis period. Growth in the Reagents & Kits segment is estimated at 7.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.0 Billion While China is Forecast to Grow at 9.8% CAGR

The Patient Blood Management market in the U.S. is estimated at US$4.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$5.6 Billion by the year 2030 trailing a CAGR of 9.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Patient Blood Management Market - Key Trends & Drivers Summarized

Why Is Patient Blood Management Essential in Modern Healthcare?

Patient Blood Management (PBM) has become a crucial component in modern healthcare, providing a systematic approach to optimize the care of patients who might need blood transfusions. PBM focuses on minimizing the need for blood transfusions by managing anemia, reducing blood loss during surgery, and optimizing patients' red blood cell mass, thereby improving clinical outcomes. The importance of PBM lies in its ability to enhance patient safety by reducing the risks associated with transfusions, such as infections, immune reactions, and transfusion-related complications. This evidence-based approach is especially important for patients undergoing surgeries, trauma cases, or those with chronic anemia, as it reduces dependency on blood products and leads to faster recovery.

By minimizing unnecessary transfusions, PBM also plays a significant role in conserving blood supplies, which are often in limited availability. This approach is vital for healthcare systems, particularly in times of blood shortages or in regions with limited access to blood products. With the rising demand for blood due to aging populations and increasing surgical procedures, PBM ensures that blood is available for patients who need it most while encouraging efficient blood use. This practice not only conserves resources but also lowers healthcare costs associated with blood transfusions, making PBM essential for sustainable healthcare management.

Moreover, PBM promotes better overall outcomes by taking a preventive, individualized approach to managing each patient's blood needs. Through interventions like iron supplementation, erythropoiesis-stimulating agents, and advanced surgical techniques, PBM prepares patients adequately before surgery or treatment. This comprehensive approach reduces the likelihood of complications, shortens hospital stays, and enhances recovery times. As healthcare increasingly emphasizes patient-centered care, PBM provides a tailored, preventive strategy that aligns with modern principles of healthcare delivery, improving both patient satisfaction and health outcomes.

How Are Technological Advancements Enhancing Patient Blood Management?

Technological advancements are significantly enhancing Patient Blood Management by introducing new tools and methods that optimize blood use, minimize blood loss, and improve patient outcomes. One key innovation in PBM is the development of advanced diagnostic tools that allow for early detection and management of anemia before surgery or treatment. Technologies like point-of-care (POC) testing and automated blood analyzers enable rapid hemoglobin assessments and iron deficiency evaluations, allowing healthcare providers to diagnose and treat anemia early. With accurate, real-time diagnostics, clinicians can implement personalized strategies to optimize hemoglobin levels in advance, reducing the likelihood of needing transfusions. These technologies support proactive anemia management, a core component of PBM, ensuring that patients are in the best possible condition before undergoing procedures.

Another major advancement in PBM is the use of cell salvage and blood-sparing surgical techniques, which minimize blood loss and reduce transfusion needs during surgery. Intraoperative cell salvage devices collect and process a patient’s blood during surgery, allowing it to be reinfused back into the patient, thus reducing dependency on donor blood. Additionally, minimally invasive and laparoscopic surgical techniques are becoming increasingly common, as they involve smaller incisions, leading to less blood loss. These techniques are particularly beneficial in high-blood-loss surgeries, such as orthopedic and cardiac procedures. By incorporating cell salvage and minimally invasive techniques, PBM reduces the need for external blood, improving surgical outcomes and supporting resource efficiency.

Pharmaceutical innovations, such as erythropoiesis-stimulating agents (ESAs) and iron supplements, are also playing a critical role in PBM by boosting red blood cell production and addressing anemia without the need for transfusions. ESAs stimulate the bone marrow to produce more red blood cells, which is especially beneficial for patients with chronic anemia or those undergoing chemotherapy. Iron supplements, whether oral or intravenous, support hemoglobin optimization, preparing patients for procedures that may involve blood loss. With these pharmaceutical interventions, PBM offers non-transfusion options for managing anemia, aligning with its goal to enhance patient health while minimizing transfusion requirements. These therapies empower clinicians to tailor PBM strategies to each patient’s needs, providing a more effective and less invasive approach to blood management.

What Are the Benefits of Patient Blood Management for Patients and Healthcare Providers?

Patient Blood Management provides significant benefits for both patients and healthcare providers, improving patient outcomes, reducing healthcare costs, and optimizing the use of limited blood supplies. For patients, PBM enhances safety by minimizing the risks associated with blood transfusions, such as infections, transfusion reactions, and immunologic complications. By employing non-transfusion interventions like anemia management, surgical blood-sparing techniques, and the use of patient’s own blood, PBM reduces the potential for adverse reactions and promotes a safer healthcare experience. For patients undergoing major surgeries, PBM offers the assurance of a carefully managed blood strategy that prioritizes their health, reduces the need for transfusions, and leads to quicker recovery times and shorter hospital stays.

For healthcare providers, PBM supports efficient and sustainable resource management by reducing reliance on donor blood, which is often in limited supply. With blood donation rates unable to keep pace with increasing demand, PBM helps preserve blood resources for patients with critical needs, such as trauma or severe bleeding cases. By reducing blood usage through optimized care and non-transfusion interventions, healthcare providers can manage resources more effectively, lowering the risk of blood shortages and ensuring that blood products are available when truly necessary. PBM also decreases costs associated with blood transfusions, including storage, screening, and administration expenses. This cost-efficiency is especially valuable in large hospitals and health systems, where managing blood resources effectively can lead to substantial financial savings.

Enhanced patient outcomes and quality of care are additional benefits of PBM, as it fosters a more patient-centered, individualized approach to healthcare. Through early anemia detection, blood-sparing surgical practices, and non-transfusion options, PBM enables healthcare providers to create personalized care plans tailored to each patient’s needs. This customized approach reduces the likelihood of complications and supports faster recoveries, improving patient satisfaction and overall quality of care. By proactively managing patients’ blood health, PBM minimizes hospital stays and readmissions, leading to a more streamlined healthcare experience. Together, these benefits improve both the clinical and operational aspects of healthcare delivery, supporting the goal of high-quality, cost-effective, and patient-centered care.

What Is Fueling the Growth in the Patient Blood Management Market?

The growth in the Patient Blood Management market is driven by the rising awareness of transfusion-related risks, increasing surgical and chronic disease cases, advancements in diagnostic and therapeutic technologies, and supportive regulatory policies promoting PBM adoption. As awareness grows around the risks and complications associated with blood transfusions, healthcare providers are increasingly seeking safer and more effective alternatives to traditional transfusion practices. Concerns over infections, immunologic reactions, and potential complications have highlighted the need for PBM programs that minimize transfusions and provide safer care options. This shift in clinical perspective has encouraged more hospitals and healthcare facilities to adopt PBM protocols, driving demand for technologies and practices that support comprehensive blood management.

Increasing numbers of surgeries and the rising prevalence of chronic diseases, such as cancer, kidney disease, and cardiovascular conditions, are also fueling the demand for PBM solutions. With these conditions often requiring surgical interventions or frequent hospitalizations, healthcare providers need effective blood management strategies to support patient care while reducing transfusion dependency. PBM protocols are particularly valuable in high-blood-loss surgeries, as they optimize patient blood health before and during procedures, decreasing the need for transfusions. As the volume of surgeries and hospitalizations continues to grow, so does the demand for effective PBM solutions to manage blood efficiently and improve patient outcomes.

Advancements in diagnostic and therapeutic technologies are significantly contributing to PBM market growth, as they enable more precise, effective, and personalized blood management strategies. New diagnostic tools, such as point-of-care testing and advanced anemia screening, allow for early intervention and accurate management of patient blood levels. Surgical innovations, including cell salvage devices and minimally invasive techniques, reduce blood loss during procedures, minimizing the need for donor blood. Pharmaceutical advancements, such as erythropoiesis-stimulating agents and intravenous iron supplements, provide non-transfusion treatment options for patients with anemia. These technological innovations make PBM programs more accessible and effective, supporting their adoption in hospitals and healthcare facilities worldwide.

Supportive regulatory policies and guidelines are also driving growth in the PBM market, as healthcare organizations and governments recognize the value of PBM in improving patient safety and optimizing blood resources. Regulatory bodies like the World Health Organization (WHO) and health ministries in several countries are encouraging healthcare providers to adopt PBM practices as part of their standard care protocols. Many healthcare systems now require hospitals to implement PBM strategies to comply with quality standards, reduce healthcare costs, and conserve blood resources. Additionally, patient advocacy groups and health organizations have increased educational efforts to promote awareness of PBM benefits among healthcare professionals and the public. These regulatory and advocacy efforts are expanding the adoption of PBM, driving significant growth in the market as providers align with best practices and compliance standards.

Together, these factors—awareness of transfusion risks, increasing surgical and chronic disease prevalence, technological advancements, and supportive regulatory frameworks—are driving robust growth in the Patient Blood Management market. As healthcare systems aim to provide safer, more cost-effective, and resource-efficient care, PBM is becoming a cornerstone of modern, patient-centered healthcare delivery.

SCOPE OF STUDY:

The report analyzes the Patient Blood Management market in terms of US$ Million by the following Component; End-Use; Product, and Geographic Regions/Countries:

Segments:

Product (Instruments, Reagents & Kits, Software, Accessories); Component (Whole Blood & Red Blood Cells, Plasma); End-Use (Blood Banks, Hospitals)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories
  • Asahi Kasei Medical Co. Ltd.
  • B. Braun Melsungen AG
  • Biomerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche LTD.
  • Fresenius Se & Co. KGaA
  • Grifols, S.A.
  • Haemonetics Corporation
  • Immucor, Inc.
  • Kaneka Corporation
  • Livanova PLC
  • Macopharma
  • Terumo Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Patient Blood Management - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Focus on Blood Conservation Drives Demand for Patient Blood Management (PBM) Solutions
    • Rising Incidence of Chronic Diseases Expands Addressable Market for PBM
    • Advancements in Blood Transfusion Technologies Propel Market Growth
    • Growing Use of Point-of-Care Hemoglobin Testing Drives PBM Solutions
    • Patient Blood Management Crucial for Enhancing Surgical Outcomes
    • Use of AI for Blood Utilization Optimization Sets the Stage for PBM Growth
    • Increasing Demand for Bloodless Surgery Expands PBM Applications
    • Innovations in Anemia Management Propel PBM Market Expansion
    • Focus on Reducing Blood Transfusion-Related Risks Drives PBM Adoption
    • Use of PBM in Oncology Care Expands Market Opportunities
    • Growing Adoption in Emergency and Trauma Care Expands PBM Applications
    • Use of PBM in Geriatric Care Strengthens Market Opportunities
    • Strategic Investments in Automated Blood Management Solutions Propel PBM Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Patient Blood Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Patient Blood Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Patient Blood Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Whole Blood & Red Blood Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Whole Blood & Red Blood Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Whole Blood & Red Blood Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Plasma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Plasma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Plasma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Blood Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 28: World Patient Blood Management Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • JAPAN
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • CHINA
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • EUROPE
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Patient Blood Management by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Patient Blood Management by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Patient Blood Management by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • FRANCE
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • GERMANY
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Patient Blood Management by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Patient Blood Management by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • INDIA
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: India 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: India 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Patient Blood Management by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Patient Blood Management by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Patient Blood Management by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Patient Blood Management by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Patient Blood Management by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Patient Blood Management by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • AFRICA
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제